These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34115086)

  • 1. Synthesis, biological evaluation and molecular modeling of urea-containing MraY inhibitors.
    Oliver M; Le Corre L; Poinsot M; Corio A; Madegard L; Bosco M; Amoroso A; Joris B; Auger R; Touzé T; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Org Biomol Chem; 2021 Jul; 19(26):5844-5866. PubMed ID: 34115086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-Methylene-triazole-substituted-aminoribosyl uridines as MraY inhibitors: synthesis, biological evaluation and molecular modeling.
    Fer MJ; Bouhss A; Patrão M; Le Corre L; Pietrancosta N; Amoroso A; Joris B; Mengin-Lecreulx D; Calvet-Vitale S; Gravier-Pelletier C
    Org Biomol Chem; 2015 Jul; 13(26):7193-222. PubMed ID: 26008868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the Structural Requirement of Uridylpeptide Antibiotics for Antibacterial Activity.
    Terasawa Y; Sataka C; Sato T; Yamamoto K; Fukushima Y; Nakajima C; Suzuki Y; Katsuyama A; Matsumaru T; Yakushiji F; Yokota SI; Ichikawa S
    J Med Chem; 2020 Sep; 63(17):9803-9827. PubMed ID: 32787111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.
    Mihalyi A; Jamshidi S; Slikas J; Bugg TD
    Bioorg Med Chem; 2014 Sep; 22(17):4566-71. PubMed ID: 25127465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified Novel Muraymycin Analogues; using a Serine Template Strategy for Linking Key Pharmacophores.
    Patel B; Kerr RV; Malde AK; Zunk M; Bugg TDH; Grant G; Rudrawar S
    ChemMedChem; 2020 Aug; 15(15):1429-1438. PubMed ID: 32476294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial transferase MraY inhibitors: synthesis and biological evaluation.
    Lecerclé D; Clouet A; Al-Dabbagh B; Crouvoisier M; Bouhss A; Gravier-Pelletier C; Le Merrer Y
    Bioorg Med Chem; 2010 Jun; 18(12):4560-9. PubMed ID: 20537545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
    Tanino T; Al-Dabbagh B; Mengin-Lecreulx D; Bouhss A; Oyama H; Ichikawa S; Matsuda A
    J Med Chem; 2011 Dec; 54(24):8421-39. PubMed ID: 22085339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward analogues of MraY natural inhibitors: synthesis of 5'-triazole-substituted-aminoribosyl uridines through a Cu-catalyzed azide-alkyne cycloaddition.
    Fer MJ; Olatunji S; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    J Org Chem; 2013 Oct; 78(20):10088-105. PubMed ID: 24044436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, molecular docking study, and antibacterial evaluation of some new fluoroquinolone analogues bearing a quinazolinone moiety.
    Norouzbahari M; Salarinejad S; Güran M; Şanlıtürk G; Emamgholipour Z; Bijanzadeh HR; Toolabi M; Foroumadi A
    Daru; 2020 Dec; 28(2):661-672. PubMed ID: 33030668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Sub-Micromolar MraY
    Oliver M; Le Corre L; Poinsot M; Bosco M; Wan H; Amoroso A; Joris B; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors.
    Dini C; Collette P; Drochon N; Guillot JC; Lemoine G; Mauvais P; Aszodi J
    Bioorg Med Chem Lett; 2000 Aug; 10(16):1839-43. PubMed ID: 10969981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial Transferase MraY, a Source of Inspiration towards New Antibiotics.
    Fer MJ; Corre LL; Pietrancosta N; Evrard-Todeschi N; Olatunji S; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C
    Curr Med Chem; 2018; 25(42):6013-6029. PubMed ID: 29600753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.
    Kwak SH; Lim WY; Hao A; Mashalidis EH; Kwon DY; Jeong P; Kim MJ; Lee SY; Hong J
    Eur J Med Chem; 2021 Apr; 215():113272. PubMed ID: 33607457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrazonoyl bromide precursors as DHFR inhibitors for the synthesis of bis-thiazolyl pyrazole derivatives; antimicrobial activities, antibiofilm, and drug combination studies against MRSA.
    Ibrahim SA; Fayed EA; Rizk HF; Desouky SE; Ragab A
    Bioorg Chem; 2021 Nov; 116():105339. PubMed ID: 34530234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muraminomicins, new lipo-nucleoside antibiotics from Streptosporangium sp. SANK 60501-structure elucidations of muraminomicins and supply of the core component for derivatization.
    Fujita Y; Kagoshima Y; Masuda T; Kizuka M; Ogawa Y; Endo S; Nishigoori H; Saito K; Takasugi K; Miura M; Murakami R; Muramatsu Y; Tokumitsu A; Koga T; Iizuka M; Aoyagi A; Suzuki T; Suzuki T; Suzuki Y; Ishida O; Nakahira T; Miyakoshi S; Konosu T; Takatsu T
    J Antibiot (Tokyo); 2019 Dec; 72(12):943-955. PubMed ID: 31413314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis.
    Hering J; Dunevall E; Ek M; Brändén G
    Drug Discov Today; 2018 Jul; 23(7):1426-1435. PubMed ID: 29778697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis of novel 4,5-dihydroisoxazole-containing benzamide derivatives as highly potent FtsZ inhibitors capable of killing a variety of MDR Staphylococcus aureus.
    Song D; Bi F; Zhang N; Qin Y; Liu X; Teng Y; Ma S
    Bioorg Med Chem; 2020 Nov; 28(21):115729. PubMed ID: 33065440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological evaluation of benzothiazole ethyl urea inhibitors of bacterial type II topoisomerases.
    Stokes NR; Thomaides-Brears HB; Barker S; Bennett JM; Berry J; Collins I; Czaplewski LG; Gamble V; Lancett P; Logan A; Lunniss CJ; Peasley H; Pommier S; Price D; Smee C; Haydon DJ
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5977-86. PubMed ID: 24041906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GroEL/ES inhibitors as potential antibiotics.
    Abdeen S; Salim N; Mammadova N; Summers CM; Frankson R; Ambrose AJ; Anderson GG; Schultz PG; Horwich AL; Chapman E; Johnson SM
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3127-3134. PubMed ID: 27184767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis.
    Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY
    Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.